WHO ICTRP trial

The effect of Bifidobacterium longum on PPI-based triple therapy for eradication…

TCTR20200804008 · Thai Clinical Trials Registry (TCTR) · Not Recruiting

Key facts

Trial ID TCTR20200804008
Public title The effect of Bifidobacterium longum on PPI-based triple therapy for eradication of Helicobacter pylori.
Scientific title The effect of Bifidobacterium longum on PPI-based triple therapy for eradication of Helicobacter pylori.
Primary sponsor Chiang Mai University
Secondary sponsors Chiang Mai University
Registry Thai Clinical Trials Registry (TCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries Thailand
Conditions Helicobacter pylori positive gastritis patients Helicobacter pylori, gastritis, probiotic;Helicobacter pylori, gastritis, probiotic
Interventions Bifidobacterium longum,Conventional PPI therapy;Experimental Drug,Active Comparator Drug;Bifidobacterium longum plus conventional ppi-based tripple therapy,conventional ppi-based tripple therapy
Registration date Apr 8, 2020
Registry page thaiclinicaltrials.org

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations